CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype

Author： Nordin C.   Dahl M.-L.   Eklundh T.   Eriksson M.   Sjoberg S.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.13, Iss.5, 2003-10, pp. : 333-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetics of ketobemidone are not affected by CYP2D6 or CYP2C19 phenotype

By Al-Shurbaji Ayman   Säwe Juliette  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 877-881

Springer Publishing Company

Access to resources Recommend Favorite

Mixture Models and Subpopulation Classification: A Pharmacokinetic Simulation Study and Application to Metoprolol CYP2D6 Phenotype

By Kaila Nitin   Straka Robert   Brundage Richard  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 2, 2007-04 ,pp. : 141-156

Springer Publishing Company

Access to resources Recommend Favorite

Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization

By  

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 218-232

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine

By Sawamura Kazushi   Suzuki Yutaro   Someya Toshiyuki  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite

Implementation of CYP2D6 genotyping in psychiatry

By Loovers Harriët M   van der Weide Jan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite